Tian N, Chen S, Han H, Jin J, Li Z
Sci Rep. 2024; 14(1):4208.
PMID: 38378872
PMC: 10879154.
DOI: 10.1038/s41598-024-54192-9.
Kunitake K, Motohashi N, Inoue T, Suzuki Y, Aoki Y
Sci Rep. 2024; 14(1):2329.
PMID: 38282008
PMC: 10822841.
DOI: 10.1038/s41598-024-52530-5.
Chen L, Chau W, Yuen H, Liu X, Qi R, Lung M
Cancers (Basel). 2023; 15(7).
PMID: 37046850
PMC: 10093038.
DOI: 10.3390/cancers15072189.
Hu P, Leyton L, Hagood J, Barker T
Front Cell Dev Biol. 2022; 10:928510.
PMID: 35733855
PMC: 9208718.
DOI: 10.3389/fcell.2022.928510.
Zeng C, Lin M, Jin Y, Zhang J
Med Sci Monit. 2022; 28:e935071.
PMID: 35296631
PMC: 8939238.
DOI: 10.12659/MSM.935071.
Targeting Cancer Stem Cells by Genetically Engineered Chimeric Antigen Receptor T Cells.
Alhabbab R
Front Genet. 2020; 11:312.
PMID: 32391048
PMC: 7188929.
DOI: 10.3389/fgene.2020.00312.
THY-1 (CD90) expression promotes the growth of gastric cancer cells.
Wang C, Zhang Z, Xu J, Wang M, Zhu C, Zhuang C
Int J Clin Exp Pathol. 2020; 10(9):9878-9888.
PMID: 31966876
PMC: 6965938.
Soluble Thy-1 reverses lung fibrosis via its integrin-binding motif.
Tan C, Jiang M, Wong S, Espinoza C, Kim C, Li X
JCI Insight. 2019; 4(21).
PMID: 31672942
PMC: 6948761.
DOI: 10.1172/jci.insight.131152.
Thy-1/CD90 a Bidirectional and Lateral Signaling Scaffold.
Leyton L, Diaz J, Martinez S, Palacios E, Perez L, Perez R
Front Cell Dev Biol. 2019; 7:132.
PMID: 31428610
PMC: 6689999.
DOI: 10.3389/fcell.2019.00132.
CD90/Thy-1, a Cancer-Associated Cell Surface Signaling Molecule.
Sauzay C, Voutetakis K, Chatziioannou A, Chevet E, Avril T
Front Cell Dev Biol. 2019; 7:66.
PMID: 31080802
PMC: 6497726.
DOI: 10.3389/fcell.2019.00066.
Single cell RNA-seq study of wild type and Hox9,10,11 mutant developing uterus.
Mucenski M, Mahoney R, Adam M, Potter A, Potter S
Sci Rep. 2019; 9(1):4557.
PMID: 30872674
PMC: 6418183.
DOI: 10.1038/s41598-019-40923-w.
Thy-1 in Integrin Mediated Mechanotransduction.
Hu P, Barker T
Front Cell Dev Biol. 2019; 7:22.
PMID: 30859101
PMC: 6397864.
DOI: 10.3389/fcell.2019.00022.
IVD progenitor cells: a new horizon for understanding disc homeostasis and repair.
Lyu F, Cheung K, Zheng Z, Wang H, Sakai D, Leung V
Nat Rev Rheumatol. 2019; 15(2):102-112.
PMID: 30643232
DOI: 10.1038/s41584-018-0154-x.
Potency of Human Urine-Derived Stem Cells for Renal Lineage Differentiation.
Choi J, Chun S, Ha Y, Kim D, Kim J, Song P
Tissue Eng Regen Med. 2019; 14(6):775-785.
PMID: 30603527
PMC: 6171660.
DOI: 10.1007/s13770-017-0081-y.
Selection and Evaluation of Specific Single Chain Antibodies against CD90, a Marker for Mesenchymal and Cancer Stem Cells.
Moazen B, Zarrinhaghighi A, Nejatollahi F
Rep Biochem Mol Biol. 2018; 7(1):45-51.
PMID: 30324117
PMC: 6175597.
Thy-1 dependent uptake of mesenchymal stem cell-derived extracellular vesicles blocks myofibroblastic differentiation.
Shentu T, Huang T, Cernelc-Kohan M, Chan J, Wong S, Espinoza C
Sci Rep. 2017; 7(1):18052.
PMID: 29273797
PMC: 5741716.
DOI: 10.1038/s41598-017-18288-9.
Thy-1 Cancer-associated Fibroblasts Adversely Impact Lung Cancer Prognosis.
Schliekelman M, Creighton C, Baird B, Chen Y, Banerjee P, Bota-Rabassedas N
Sci Rep. 2017; 7(1):6478.
PMID: 28744021
PMC: 5527099.
DOI: 10.1038/s41598-017-06922-5.
CD90 positive cells exhibit aggressive radioresistance in esophageal squamous cell carcinoma.
Wang Y, Zhang C, Zhu H, Tang J, Zhang S, Luo J
J Thorac Dis. 2017; 9(3):610-620.
PMID: 28449469
PMC: 5394075.
DOI: 10.21037/jtd.2017.03.28.
Relevance of meniscal cell regional phenotype to tissue engineering.
Grogan S, Pauli C, Lotz M, DLima D
Connect Tissue Res. 2016; 58(3-4):259-270.
PMID: 27925477
PMC: 5433889.
DOI: 10.1080/03008207.2016.1268604.
Identification of two distinct mesenchymal stromal cell populations in human malignant glioma.
Svensson A, Ramos-Moreno T, Eberstal S, Scheding S, Bengzon J
J Neurooncol. 2016; 131(2):245-254.
PMID: 27757723
PMC: 5306185.
DOI: 10.1007/s11060-016-2302-y.